Article Details

Abivax Phase 3 Program with Obefazimod in Ulcerative Colitis Progresses with US IRB Approval

Retrieved on: 2022-08-04 16:34:37

Tags for this article:

Click the tags to see associated articles and topics

Abivax Phase 3 Program with Obefazimod in Ulcerative Colitis Progresses with US IRB Approval. View article details on HISWAI: http://www.baystreet.ca/viewarticle.aspx%3Fid%3D710875

Excerpt

... a phase 3 clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory ...

Article found on: www.baystreet.ca

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up